AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Optomed Oyj

Major Shareholding Notification Jul 2, 2024

3329_mrq_2024-07-02_4d136e66-72f9-414e-b5d2-10143673a1f7.html

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

Disclosure 448363

Optomed Oyj - Major shareholder announcements

Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings

Optomed PlcStock Exchange Release2 July 2024 at 10.45, Helsinki Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings Optomed Plc (“Optomed” or the “Company”) has received a notification in accordance with the Chapter 9, Section 5 of the Finnish Securities Markets Act (as amended, the “SMA”) from Sp Rahastoyhtiö Oy (“Notifier”). According to the notification, the total holdings in Optomed shares and votes held the investment funds of Sp-Rahastoyhtiö (Säästöpankki Pienyhtiöt, Säästöpankki Kotimaaa)is 6.51 per cent of all of the registered shares in Optomed on 1 July 2024. The total number of the Company's registered shares amounts to 19,630,397 shares. Each share entitles to one vote. The total position of Notifier subject to the notification: +----------------+----------+------------------+-----+----------------------+ | |% of |% of shares and |Total|Total number of shares| | |shares and|voting rights |of |and voting rights of | | |voting |through financial |both |issuer | | |rights |instruments (total|in % | | | |(total |of B) |(A+B)| | | |of A) | | | | +----------------+----------+------------------+-----+----------------------+ |Resulting |6.51 % | |6.51 |19630 397 | |situation on the| | |% | | |date on | | | | | |which threshold | | | | | |was crossed or | | | | | |reached | | | | | +----------------+----------+------------------+-----+----------------------+ |Position of | | | | | |previous | | | | | |notification | | | | | |(if applicable) | | | | | +----------------+----------+------------------+-----+----------------------+ Notified details of the resulting situation on the date on which the threshold was crossed or reached: A: Shares and voting rights +------------+-----------------+----------------+-----------------+-----------+ |Class/type |Number of shares and voting rights|% of shares and voting rights| |of shares | | | | | | | |ISIN code | | | +------------+-----------------+----------------+-----------------+-----------+ |Direct |Indirect |Direct |Indirect | |(SMA 9:5) |(SMA 9:6 and 9:7)|(SMA 9:5) |(SMA 9:6 and 9:7)| +------------+-----------------+----------------+-----------------+-----------+ |FI4000410881|1278 107 | |6.51% | | +------------+-----------------+----------------+-----------------+-----------+ |SUBTOTAL A |1278 107 |6.51 % | +------------+-----------------+----------------+-----------------+-----------+ Further enquiries Sakari Knuutti, CFO, Optomed Plc, [email protected] Optomed in Brief Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye diseases, such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries. www.optomed.com

Talk to a Data Expert

Have a question? We'll get back to you promptly.